期刊文献+

Safety of rectal indomethacin(100 mg)for the prevention of post-ERCP pancreatitis in the Japanese population:A single-center prospective pilot study

下载PDF
导出
摘要 To the Editor:Endoscopic retrograde cholangiopancreatography(ERCP)causes adverse events;post-ERCP pancreatitis(PEP)is one of the frequent adverse events.Recently,the efficacy of rectal administration of non-steroidal anti-inflammatory drugs(NSAIDs)before or after ERCP for PEP prevention has been reported[1].
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2022年第4期406-408,共3页 国际肝胆胰疾病杂志(英文版)
关键词 PREVENTION ERCP DRUGS
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部